Effective training of squat exercise -- HiSquat trial for ...
Transcript of Effective training of squat exercise -- HiSquat trial for ...
ïŒ 1 ïŒ
Glycative Stress ResearchOnline edition : ISSN 2188-3610
Print edition : ISSN 2188-3602Received : December 23, 2015
Accepted : February 19, 2016Published online : June 30, 2016
Glycative Stress Research 2016; 3 (2): 65 -73æ¬è«æãåŒçšããéã¯ãã¡ããåŒçšããŠãã ããã
(c) Society for Glycative Stress Research
Original article
Hiroshi Bando 1, 2), Masao Kan 3), Yuko Takenaka 2, 4), Hiroki Yokoyama 5), Takumi Nakamura 2, 6), Kiyoshi Konoike 2)
1) The University of Tokushima / Kitajima Taoka Hospital, Tokushima, Japan 2) Japan Mastersâ Association, Japan3) Japan Ship Machine Tool Co. Ltd., Japan4) Graduate School of Human Development and Environment, Kobe University, Kobe, Hyogo, Japan5) Jiyugaoka Yokoyama Clinic, Obihiro, Hokkaido, Japan6) Nakamura Orthopedic Clinic and Anti-aging Center, Kawanishi, Hyogo, Japan
Glycative Stress Research 2016; 3 (2): 65 -73(c) Society for Glycative Stress Research
Effective training of squat exercise -- HiSquat trial for patients with diabetes --
ïŒåèïŒã¹ã¯ã¯ããã®å¹æçãã¬ãŒãã³ã°ïœç³å°¿ç ã«å¯Ÿãããã€ã¹ã¯ã¯ããã®è©Šè¡ïœ
æé²
æ¿æ±æµ© 1, 2)ãè æ£å€« 3)ã竹äžåªå 2, 4)ã暪山å®æš¹ 5)ãäžæ å·§ 2, 6)ãéŽ»æ± æž åž 2)
1) ããããŸç°å²¡ç é¢ /埳島倧åŠ2) å ¬ç瀟å£ïŒæ¥æ¬ãã¹ã¿ãŒãºéžäžç«¶æé£å3) æ¥æ¬è¹è¶å·¥å ·æéäŒç€Ÿ4) ç¥æžå€§åŠå€§åŠé¢äººéçºéç°å¢åŠç 究ç§5) èªç±ãäžæšªå±±å ç§ã¯ãªããã¯6) äžææŽåœ¢å€ç§ã¯ãªãã㯠/ã¢ã³ããšã€ãžã³ã°ã»ã³ã¿ãŒ
èæ¯ïŒœè¿å¹Žããã©ã€ããªã»ã±ã¢ã®é åã§ã¯ãç³å°¿ç ãå«ãã¡ã¿ããªãã¯çå矀ããã³ã¢ãã£ãçå矀ããã¬ã€ã«ãªã©ãåé¡ã§ãããããã§ããããã®æ£è ã«å¯Ÿããéåçæ³ã«ã€ããŠãæé žçŽ éåã«å ããŠé©åãªã¬ãžã¹ã¿ã³ã¹éåã®å¿ èŠæ§ãæè¿å«ã°ãããã©ã€ããªã»ã±ã¢ã®ã¬ãã«ã§ãå¯èœã§ç°¡æœã§æå¹ãªã¬ãžã¹ã¿ã³ã¹éåãæ±ããããŠãããæ¹æ³ïŒœå¯Ÿè±¡è ã¯ç³å°¿ç æ£è 61 äŸïŒç·æ§ 36ãå¥³æ§ 25ã66.9 ± 13.5 æ³ , å¹³å±æšæºåå·®ïŒã§ãããæ¹æ³ã¯ããã€ã¹ã¯ã¯ããïŒã¹ã¯ã¯ããçšéåçšå · 3179684 å·ïŒã䜿ã£ãŠã¹ã¯ã¯ããéåããåæ£è ãèªå® ã§æå€ã«å 5 åè¡ã 6 ã«æç¶ç¶ãããåäœã¯æ©è¡ã»ãžã§ã®ã³ã°ãå€§è ¿éšå åŽã»å€åŽã»äžå€®ãéãããã®ã§ã枬å®é ç®ã¯ã身é·ãäœéãBMIãè ¹å²ãå€§è ¿åšå²åŸãHbA1c å€ãªã©ã§ãããæ²»çã¯ååçã«å€ãã HbA1c ã®å€åãæ¯èŒããã
èè é£çµ¡å ïŒ æ¿æ±ã浩 090-3187-2485ã[email protected]://pianomed-mr.jp/ãeFAX: 088-603-1030770-0943 埳島åžäžæåçº 1 äžç® 61
ïŒ 2 ïŒ
Glycative Stress Research
KEY WORDS: ãã€ã¹ã¯ã¯ãããã¹ã¯ã¯ãããç³å°¿ç ãHbA1cãéåçæ³
ã¯ããã«ãè¿å¹Žããã©ã€ããªã»ã±ã¢ã®é åã§ã¯ãç³å°¿ç ãå«ãã¡ã¿
ããªãã¯çå矀ãäžé«å¹Žè ã«ããããã³ã¢ãã£ãçå矀ããã¬ã€ã«ãã¢ã³ããšã€ãžã³ã°ç察å¿ãªã©ãåé¡ãšãªã£ãŠããŠããããããã®ã¡ã¿ããªãã¯çå矀ããã³ã¢ãã£ãçå矀ã®æ£è ã«å¯ŸããŠãæé žçŽ éåã«å ããŠã¬ãžã¹ã¿ã³ã¹éå
ïŒçãã¬ã軜ãç¡é žçŽ éåïŒãå¿ èŠãšãããŠããããã®äžã§ãéåäžè¶³ã®äººã ãé«é »åºŠãšãªã£ãŠããçŸåšããã©ã€ããªã»ã±ã¢ã®ã¬ãã«ã§ã誰ããç¶ããããç°¡çŽ ãªã¬ãžã¹ã¿ã³ã¹éåãæ±ããããŠããã
éåäžè¶³ãšçŸç ãšã®é¢ä¿ãè°è«ãããŠããŠããã身äœæŽ»åã«é¢ããã¬ã€ãã©ã€ã³ãååœã§çºè¡šãããŠããŠãã 1-5)ãå€æ°ã®æç®ã«ãã系統çã¬ãã¥ãŒãšã¡ã¿è§£æãè¡ããã座äœæéãæ ¢æ§çŸæ£ãæ»äº¡çãšé¢ãããéåã掻åã«ããæ¹åãå ±åãããŠãã 6, 7)ã系統çã¬ãã¥ãŒãšã¡ã¿è§£æã«ãããš 8)ããã¹ã¯ã¯ãŒã¯ã趣å³ïŒãã¬ãã®èŠèŽãªã©ã§åäœæéãé·ã人ã§ã¯ãéå匷床ã«ãããããå šæ»äº¡ããããå¿è¡ç®¡çŸæ£ïŒCVDïŒã2 åç³å°¿ç ãªã¹ã¯ãé«ããç¹ã«ã2 åç³å°¿ç ãªã¹ã¯ã®ãã¶ãŒãæ¯ã¯ 1.91ãšæ¥µåºŠã«é«ããéåäžè¶³ã®ã¡ã¿ããªãã¯çå矀ãåè硬åçŸæ£ãžã®åœ±é¿ãå ±åãããã
ä»æ¹ãéåäžè¶³ã«å¯ŸããŠãšã¯ãµãµã€ãºã®å¿ èŠæ§ãå«ã°ããŠããŠãããæé žçŽ éåãšã¬ãžã¹ã¿ã³ã¹éåã®äž¡è ãããããé±ã« 2 å以äžå€§ããªçèã®ã¬ãžã¹ã¿ã³ã¹éåããWHO ãä»åœã§ã®ã¬ã€ãã©ã€ã³ã§å¿ èŠãšããã 1, 2)ãã¬ãžã¹ã¿ã³ã¹éåïŒçå / ãŠã§ã€ããã¬ãŒãã³ã°ïŒã§ã¯ãçè¥å€§ãçååäžïŒçãã¯ãŒåäžãçæä¹ ååäžãªã©ã®å¹æããã9)ãããã«ãå 霢ã«äŒŽãçéã®æžå°ã骚å¯åºŠã®æžå°ãçæ©èœãç代è¬èœåã®äœäžãäœèèªã®å¢å ãªã©ã«å¯ŸããŠãæç㧠10)ãæ¥åžžç掻ã§ã®èº«äœæŽ»åããã©ãŒãã³ã¹åäž 9)
ã«ãå¹æãæåŸ ããããé«éœ¢è ã®ã¬ãžã¹ã¿ã³ã¹ã®ã¡ã¿è§£æã§ã¯ 11)ãé«éœ¢è ã®çåã®æ¹å㯠20 ïœ 30 ïŒ ãèŠèŸŒãŸãããšããã
è¿å¹Žã¯ã¡ã¿ãããã³ã¢ããã¬ã€ã«ãžã®å¯Ÿå¿ãå«ã°ããŠãããæ¥æ¬æŽåœ¢å€ç§åŠäŒãªã©ã§ããæ®å掻åãè¡ãããŠãã12, 13)ãäžã§ããæ¥æ¬è幎å»åŠäŒã«ãããã³ã¢ãã£ãã·ã³ã
ããŒã ïŒéååšçå矀ïŒã®ã¬ã€ãã©ã€ã³ã«ããç¹ã«æ©åšã䜿ããç°¡åã§ãQOL ã ADL ã«æå¹æ§ãæåŸ ããããããã¹ã¯ã¯ãããæšå¥šãããŠãã14, 15)ã
以äžã® 2 ã€ã®é åã§ãæã ã¯æå 霢å»åŠãç³å°¿ç ãé£äºã»éåçæ³ã«é¢ããå€ãã®ç 究ãè¡ã£ãŠãã 16-18)ãä»åã®ç 究ã¯ãéåçæ³ã«å¯Ÿããã¹ã¯ã¯ããã®å¹æã®æ€èšŒã§ãããæ°ããåšæ©ã§ããããéååšããã€ã¹ã¯ã¯ãã 19, 20) ãçšããŠãèšåºçã«ç³å°¿ç æ£è ã«å¯Ÿããéåçæ³ã®å¹æã 6 ã«æ解æããã®ã§ãå ±åããã
察象ãšæ¹æ³å¯Ÿè±¡è ã¯åŸ³å³¶çå ã®å»çæ©é¢ã«éé¢äžã®ç³å°¿ç æ£è 61
äŸïŒç·æ§ 36ãå¥³æ§ 25ã66.9 ± 13.5 æ³ , å¹³å±æšæºåå·®ïŒãšãããç³å°¿ç æ²»çã®å èš³ã¯é£äºéåçæ³ã®ã¿ 7 äŸãçµå£ç³å°¿ç è¬äœ¿çšè 46 äŸãã€ã³ã¹ãªã³äœ¿çšè 8 äŸã§ãã£ããçµå£ç³å°¿ç è¬ã®äœ¿çšå èš³ã¯ãã€ã³ã¹ãªã³åæ³ä¿é²å€ 9 äŸããããŠç³åžåé»å®³å€ 17 äŸãã€ã³ã¹ãªã³æµææ§æ¹åè¬ 28 äŸãã€ã³ã¯ã¬ãã³é¢é£è¬ 39 äŸãSGLT2 é»å®³å€ 2 äŸã§ãã£ããéåçæ³ã«å¶éããã網èçãè çãæããæ£è ãé€ããå幎éã«ããããããžã§ã¯ããç¶ç¶ããã
æ¹æ³ã«ã€ããŠã被éšè ã¯èªå® ã§æãšå€ã«å 5 åãã€ãã¹ã¯ã¯ããéåã 6 ã«æè¡ã£ããã¹ã¯ã¯ããã¯éååšæ©ããã€ã¹ã¯ã¯ãããïŒã¹ã¯ã¯ããçšéåçšå · 3179684 å·ïŒãçšããŠãåæ£è ãèªå® ã§æå€ã«å 5 åè¡ã 6 ã«æç¶ç¶ããã
ïŒå³ 1ïŒ19, 20)ãã¹ã¯ã¯ããã®æ·±ãã¯ã¯ã©ãŒã¿ãŒããããŒãã§ãããèéšã 1 åæ¯ã«å³åŸããå·ŠåŸããžãšäº€äºã«ãããæ¹æ³ã§è¡ã£ãããã®å 容ã瀺ãã1) æ©è¡ãããã¯ãžã§ã®ã³ã°ã§ 2 åéãè °ã¯ç¹ã«äœããããè¿ãã«æ€ åã眮ããŠæã§æ¯ããªããæœè¡ã 2) å è¡ã®å§¿å¢ã§è °ãäžããŠå·Šå³åŸåŸ© 10 å
ïŒãããã 1 åïŒã¹ã¯ã¯ãããæœè¡ã3) å€è¡ã®å§¿å¢ã§ 2) ãšåæ§ã«æœè¡ã4 ) èãã¹ãã¬ãŒãã®äœçœ®ã«ä¿ã¡ã2) ãšåæ§ã«æœè¡ãåèšã§ 5 åã»ã©ã§ãããã¹ã¯ã¯ããéåã®è©³çŽ°ã¯ã解説æ¬ããã³ããŒã ããŒãžäžã§ç€ºãããŠãã 19, 20)ã
èšåºç察å¿ã«ã€ããŠãæ£è ã¯ç³å°¿ç ã®å€æ¥æ£è ã§ãæ¬ç 究ãéå§ãã以åã®æ²»çïŒé£äºãè¬ç©ïŒãä»ã®æ¡ä»¶ãªã©ãååçã«å€ããã«ãæ¬ç 究ãè¡ã£ãã
çµæç 究éå§å㧠61 äŸã®åºç€ããŒã¿ã¯ãèº«é· 159.4 ± 8.4 cmãäœé 62.5 ± 13.8 kgãBMI å€ 24.5 ± 4.7 kg/m2ãè ¹å² 86.8 ± 10.7 cmãå€§è ¿åšå²åŸ 42.9 ± 6.4 cmãHbA1c 6.8 ± 0.9 % ã§ãã£ãã6 ã«æåŸã® HbA1cå€ã¯ 6.4 ± 1.0 % ã§ãçµ±èšåŠçã« 0.4 % ã®ææã®äœäžãèªãããããçžé¢åæã§ã¯ãBMI ãšå€§è ¿åšå²åŸ / 身é·æ¯ã«ææã®æ£ã®çžé¢ãã幎霢ãšå€§è ¿åšå²åŸ / è ¹å²æ¯ãææã®è² ã®çžé¢ãã¿ããããçµè«ïŒœæ¬ç 究㧠HbA1c ã®ææã®äœäžãã¿ãããç³å°¿ç ã«å¯Ÿããéåçæ³ã«ãããŠããã€ã¹ã¯ã¯ããïŒHiSquatïŒã®æå¹æ§ã瀺åããããæ¬ç 究ã¯ãéåçæ³ã«ãããè ¹å²ã»å€§è ¿åšå²åŸã®åºç€ããŒã¿ãä»åŸæŽ»çšãäºæ³ãããæ¬åšæ©ã®æå¹æ§ã®ããŒã¿ãšãªãããã®çµæãæ¥æ¬ã®ãã©ã€ããªã»ã±ã¢é åã§å¢å ããã¡ã¿ããªãã¯çå矀ããã³ã¢ãã£ãçå矀ããã¬ã€ã«ã«å¯Ÿããå¹æãæåŸ ãããã
ïŒ 3 ïŒ
ç³å°¿ç ã«å¯Ÿããã¹ã¯ã¯ããã®å¹èœ
枬å®é ç®ã¯ã身é·ãäœéãBMIïŒäœéææ°ãè¥æºææ°ïŒãè ¹å²ïŒèãéãæ°Žå¹³ã«æž¬å®ïŒãå€§è ¿åšå²åŸïŒèè骚äžçžããäžæ¹ 10 cm ã«ãããŠæ°Žå¹³ã«æž¬å®ããåšå²åŸïŒãHbA1c å€ãªã©ã§ãã£ãã䞻㫠HbA1c å€ã®å€åã解æããå®æœåã®ããŒã¿ã¯ã0 ã«æã® HbA1c ã®å¹³åå€ããå®æœåŸã®ããŒã¿ã¯ 6 ã«æãš 7 ã«æã® HbA1c ã®å¹³åå€ãçšããã以äžãããå€§è ¿åšå²åŸ / 身é·æ¯ãå€§è ¿åšå²åŸ / è ¹å²æ¯ãªã©ãå«ããããŒã¿ã«ã€ããŠçžé¢é¢ä¿ã解æããã
ãå«ççåŽé¢ãšããŠãæ¬ç 究ã¯ïŒãã«ã·ã³ã宣èšããã³æ¬éŠã®å人æ å ±ä¿è·æ¡äŸãåççã«ãã GCP ã«æºæ ããŠè¡ã£ããæ¬ç 究ã«å¯ŸããŠã¯å«çå§å¡äŒãèšçœ®ãããæ¬ã¢ã³ã±ãŒãã«åçããåå人ããã€ã³ãã©ãŒã ãã³ã³ã»ã³ããåŸãã
çµæ1) 察象è ã®åºç€ããŒã¿ïŒæ¬ç 究éå§åã®åºç€ããŒã¿ãšã
ãŠã ãè¡š 1ã«ã BMIã®ååžãå³ 2ã«ç€ºããã BMIïŒäœéææ°ïŒ 㯠24.5 ± 4.7 kg/m2ãHbA1c ïŒåå€ïŒ 㯠6.8 ± 0.9 % ïŒå¹³å±æšæºåå·®ïŒã§ãã£ã ïŒè¡š 1ïŒã61 äŸã® BMI ã®ååžãå³2 ã«ç€ºãã25 以äžã¯ 61 äŸäž 23 äŸïŒ37.8 %ïŒã§ãã£ãã
2) HbA1c ã®å€åïŒ6 ã«æåŸã® HbA1c å€ã¯ 6.4 ± 1.0 % ïŒå¹³å±æšæºåå·®ïŒã§ãå¹³å 0.4 % çµ±èšåŠçã«ææãªäœäžïŒp<0.05ïŒãèªããããïŒå³ 3ïŒã61 äŸã«ããã HbA1c å€ã®å€åïŒäœäžïŒã®çšåºŠãå³ 4 ã«ç€ºãã61 äŸäž 32 äŸïŒ52.4 %ïŒã§ 0.3 % 以äžäžéããã
3) åå åã®çžé¢é¢ä¿ïŒæ矩深ãçžé¢é¢ä¿ã®çµæãå³ 5 ã«ç€ºãããææã®æ£ã®çžé¢ããè ¹å² vs å€§è ¿åšå²åŸïŒaïŒãBMI vs å€§è ¿ / 身é·æ¯ïŒbïŒãBMI vs è ¹å² / 身é·æ¯ïŒcïŒã«ã¿ãããææã®è² ã®çžé¢ã幎霢ãšå€§è ¿ / è ¹å²æ¯ïŒeïŒã«èªãããããäžæ¹ãBMI ãšå€§è ¿ / è ¹å²æ¯ïŒdïŒã HbA1c å€åéãš HbA1cã®æ°å€ïŒåå€ãå€åéãåŸå€ïŒãšä»ã®å åãšã®éïŒfïŒã«ã¯ãææã®çžé¢ã¯èªããããªãã£ãã
èå¯ã»èº«äœæŽ»åéãšç³å°¿ç
身äœæŽ»åéãšç³å°¿ç ãã¯ããæ§ã ãªç掻ç¿æ £ç ã®çºçã«é¢ããããšãç«åŠèª¿æ»ã§æããã«ãããŠãããéåäžè¶³ãšçŸç ã«ã€ããŠã系統çã¬ãã¥ãŒãšã¡ã¿è§£æãè¡ãããThorp ã 48 件 6)ãWilmot ã 18 件 7)ãBiswas ã 47 件 8)
ã§æ€èšãããBiswas ã瀺ããã®ã¯ããªã¹ã¯ã®äžæã«ããããã¶ãŒãæ¯ã¯å¿èè¡ç®¡æ»äº¡ç1.179ãå¿èè¡ç®¡æç ç1.143ãçæ»äº¡ç 1.173ãççºçç 1.130ã2 åç³å°¿ç çºçç 1.910ã§ãã£ã 8)ã
ãŸããæ¥åžžçã«ãã¬ãèŠèŽã 5 æé以äžã®äººã¯ 1 æéæªæºãšæ¯ã¹ãŠ 2 åç³å°¿ç çºçã®ãªã¹ã¯ïŒãã¶ãŒãæ¯ïŒã¯1.86 ïŒ95% CI: 1.54--2.24ïŒãšå¢å ãããšãã 21)ãããã«ã座äœæéãççž®ãããä»å ¥ã«ãã£ãŠãé£åŸè¡ç³ãšã€ã³ã¹ãªã³åå¿ã®æ¹åãå ±åãããŠãã 22)ããããã®è«æãããLynch 23) ã¯ãšãã£ããªã¢ã«ã®äžã§ãä»åŸã¯ãµãã°ã«ãŒãã®ç 究ãå¿ èŠã§ããããšè¿°ã¹ãŠããã
身äœæŽ»åã«é¢ããã¬ã€ãã©ã€ã³ã«é¢ã㊠1, 3-5)ãWHO ã®èº«äœæŽ»åã®å¥åº·æšå¥šåºæºã«ã¯ã幎霢å¥ã«æšå¥šã¬ãã«ãèšèŒãããŠãã 1)ã18-64 æ³ããã³ 65 æ³ä»¥äžã®ããããã§ãäžãã匷ã®æé žçŽ éåã®å¿ èŠæ§ã«å ããŠããé± 2 æ¥ãŸãã¯ãã以äžã倧ç矀ã䜿ãçåãã¬ãŒãã³ã°ãããããšããšã®èšèŒãããã
ãŸãã座äœãªã©äžåã®ç掻ã«ããã®äžå©çã瀺ãããŠããããªãŒã¹ãã©ãªã¢æ¿åºã®ã¬ã€ãã©ã€ã³è³æã®è¡šçŽã«ã倧ãã âMake your Move â Sit less â Be active for life!âãšèšèŒãããã泚ç®ããã 3)ããããŠãå€å°ã®éåãè¡ã£ãŠãé·æéã® sitting ã®åœ±é¿ã倧ãããšãã 24)ã
æ¥æ¬ã®å€§èŠæš¡èª¿æ»ãšããŠãJPHC study 㯠45-74 æ³ã®æ¥æ¬äºº 83,034 åã«ããã³ããŒãç 究ã§ãæ¥åžžèº«äœæŽ»åãšæ»äº¡çãšã®é¢ä¿ãæ€èšãããã察象è ã 4 åå²ãã矀ã§ãæãäœã矀ãšæ¯èŒããŠã身äœæŽ»åãäžãããšæ»äº¡çã¯äœäžãããã®çšåºŠã¯ãç·æ§ã§ 0.79ã0.82ã 0.73ã女æ§ã§ç·å¥³ 0.75ã0.64ã 0.61 ã§ãã£ã 25)ãJPHC ã®äžé£ã®çãªã¹ã¯ãšã®ç 究
Fig. 1. HiSquat (the exercise equipment for squat movement)
ïŒ 4 ïŒ
Glycative Stress Research
ã§ãé±ã« 1 å以äžã®ã¹ããŒããéåãè¡ã£ãŠãã人ã¯ãåæ§ã«ã4 å矀ã§ãæãäœã矀ãšæ¯èŒã㊠0.80ã0.81ã0.61ãšäœäžãã¿ããã 26)ããã®ããã«ãæ¥æ¬äººã«ããã調æ»ã§ããã¹ããŒããéåã«ããå©çãèªããããã
ã»ç 究ããŒã¿ã®è§£æä»åç 究察象ãšãªã£ãç³å°¿ç æ£è 61äŸã®èæ¯å åïŒè¡š
1ïŒãã¿ããšãäœæ Œã BMIïŒå³ 2ïŒããç®åºããè¥æºå²åã¯23/61ïŒ37.7 %ïŒã§ãéåžžã®å€æ¥ã§ç³å°¿ç æ£è ã®è¥æºé »åºŠãšåçãšæãããã
ã¯ããã«ãæ¬ç 究㧠HbA1c ã®å¹³å 0.4 % ã®äœäžïŒå³ 3ïŒãšãHbA1c äœäžã®ååžïŒå³ 4ïŒãšã®äž¡è ãããã©ã®ãããªæ£è ã« HbA1c äœäžãã¿ãããããã®ããåæããã
ãã®çµæãBMI ãšã®é¢é£æ§ã¯äœãããããžã§ã¯ãéå§æã® HbA1c å€ãšã®é¢é£ãè¥å¹²æšæž¬ããããããã§ãHbA1cã®åå€ã§ A 矀㚠B 矀㮠2 矀ã«åããHbA1c å€ã®äœäžã®çšåºŠãæ€èšãA 矀ïŒåå€ lower 矀 ïŒ6.5 % 以äžãn=30ïŒã§ã¯
HbA1c å€ã®äœäžã¯å¹³å 0.11 ± 0.35 %ãäžå€®å€ 0.175 % ã§ãã£ããäžæ¹ãB 矀ïŒåå€ higher 矀ïŒ6.6 % 以äžãn=31ïŒã§ã¯ãHbA1c å€ã®äœäžã¯å¹³å 0.69 ± 1.08 %ãäžå€®å€ 0.65 %ã§ãã£ãã61äŸå šäœã§ HbA1c å€ã®äœäžã¯ 0.41± 0.86 %ãäžå€®å€ 0.30 % ã§ãã£ãã
以äžããããã€ã¹ã¯ã¯ããã«ããå¹æã¯ãã³ã³ãããŒã«ã®è¯å¥œçŸ€ã§ã¯å°ãªããã³ã³ãããŒã«ã®äžè¯çŸ€ã§ã¯ HbA1cã®äœäžã倧ãããšæšæž¬ã§ããããã€ãŸãããã©ã€ããªã»ã±ã¢ã®èšåºçŸå Žã§ãç³å°¿ç ã®ã³ã³ãããŒã«ãé£ããã±ãŒã¹ã§ããã€ã¹ã¯ã¯ããã«ããéåçæ³ãè©Šã¿ãæ矩ããããšæãããã
çžé¢åæãã次ã®ããã«æšæž¬ãã ïŒå³ 5ïŒã1) è ¹å²ãå€§è ¿åšå²åŸãBMI ã«ã¯çžäºã®æ£ã®çžé¢ããããä»åŸãå€§è ¿åšå²åŸããè ¹å² / 身é·æ¯ãå€§è ¿åšå²åŸ / 身é·æ¯ãªã©ããèšåºçã»çµ±èšåŠçã«ãæçšãªå åãšãªããšç€ºåãããïŒå³ 5. a, b, cïŒã 2) å³ 5. c ãš d ã®æ¯èŒãããå€§è ¿åšå²åŸ / 身é·æ¯ã¯ãã誀差ãå°ãªããå€§è ¿ / è ¹å²æ¯ããçµ±èšçã«æçšãªå åãšèããããã3) å³ 5. d, e ã®æ¯èŒãããå€§è ¿åšå²åŸ / è ¹å²æ¯ã幎霢
Fig. 2. Body Mass Index (BMI) distribution of 61 subjects.
mean ± SD
159.4 ±
62.5 ±
24.5 ±
86.8 ±
42.9 ±
6.8 ±
6.4 ±
8.4 cm
13.8 kg
4.7 kg/m2
10.7 cm
6.4 cm
0.9 %
1.0 %
height
body weight
body mass index (BMI)
abdominal circumference
thigh circumference
HbA1c (before)
HbA1c (6 months)
Table 1. fundamental data
16ïœ 18ïœ 20ïœ 22ïœ 23ïœ 25ïœ 27ïœ 29ïœ
3
6
910 10
8 8
7
0
10
5
15(n)
BM I (kg/m2)
ïŒ 5 ïŒ
ç³å°¿ç ã«å¯Ÿããã¹ã¯ã¯ããã®å¹èœ
Fig. 3. The changes of HbA1c value in 61 patients with diabetes mellitusThere was a significant difference between the two (P< 0.05, paired-t test).
Fig. 4. The distribution of the decrease of HbA1c value in the patients with diabetes mellitus
before 6 months
6.8%
6.4%
5
6
7(%)
HbA1c
45 5
15
8
13
11
⊠- 0.3 - 0.1ïœ-0.2
0 0.1ïœ0.2
0.3ïœ0.4
0.5ïœ0.9
1.0 âŠ0
15
10
5
20(n)
Decrease of HbA1c (%)
ïŒ 6 ïŒ
Glycative Stress Research
Fig. 5. Correlation among body mass index (BMI), waist circumference, thigh circumference, thigh/waist circumference ratio, thigh/height ratio and age.a. Correlation between thigh and waist circumference (significant correlation, p<0.05)b. Correlation between BMI and thigh/height ratio (significant correlation, p<0.001)c. Correlation between BMI and waist/height ratio (significant correlation, p<0.001)d. Correlation between BMI and thigh/waist ratio (no significant correlation)e. Correlation between age and thigh/waist ratio (significant correlation, p<0.05)f. Correlation between thigh/waist ratio and decreased HbA1c (no significant correlation)
70
65
60
55
50
45
40
35
3050 60 70 80 90
waist circumference (cm)
thigh circumference (cm)
100 110 120 130
45
40
35
30
25
20
15
105 10 15 20 25
Body Mass Index
thigh/height ratio (%)
30 35 40 45
90
80
70
60
50
40
305 10 15 20 25
Body Mass Index
waist/height ratio (ïŒ )
30 35 40 45
70
65
60
55
50
45
40
355 10 15 20 25
Body Mass Index
thigh/waist ratio (%)
30 35 40 45
70
60
65
55
50
45
40
35
300 20 40
age (y.o.)
thigh/waist ratio (ïŒ )
60 80 100
2.5
2
1.5
1
0.5
0
- 0.5
- 1
- 1.530 35 40 45 50
thigh/waist ratio (%)
decreased HbA1c (%)
55 60 65 70
y=0.39x + 9.27r = 0.46p=0.02
a.
y=0.69x + 10.1r = 0.52p<0.001
b.
y=1.29x + 22.9r =0.57p<0.001
c.
y= 0.09x + 47.9r = 0.14, p= 0.28
d.
y= - 0.17x + 61.7r = 0.41p= 0.04
e.
y= - 0.0006x + 0.42r = 0.34, p= 0.06
f.
ïŒ 7 ïŒ
ç³å°¿ç ã«å¯Ÿããã¹ã¯ã¯ããã®å¹èœ
ãšã®è² ã®çžé¢ã®ååšã«ãããå 霢ã«ããçèéã®äœäžã瀺åããå¯èœæ§ãèããããã4) å³ 5. f ãå«ã HbA1c ã®æ°å€ïŒåå€ãå€åéãåŸå€ïŒãšä»ã®ãã¹ãŠã®å åãšã®éã«çžé¢ã¯ã¿ãããªãã£ãããã®äžå ãšããŠãç³è³ªå¶éãªã©ã®é£äºçæ³ã§æãããªäœéæžå°ãã¿ãããå Žåãšã¯ç°ãªããå幎çšåºŠã®éåçæ³ã§èæãªè ¹å²æžå°ãªã©ãã¿ããã«ãããããšèããããã
BMIïŒäœéææ°ïŒãšå€§è ¿åšå²åŸã«ã€ããŠãäžèšã®ç¹ã«çæããŠè©äŸ¡ãè¡ã£ãã1) BMI ã¯èº«é·ãšäœéããèšç®ããçèãèèªã®æ¯çãèæ ®ãããŠããªããããBMI ã®è©äŸ¡ã«ã¯ããçšåºŠéçãããã2) ã¹ã¯ã¯ããéåãéå§ããåŸã®å€§è ¿åšå²åŸã®è©äŸ¡ã«ã¯æ§ã ãªå€åå åãå«ãŸããããšãã°æ©æã«ã¯ç®äžèèªã®æžå°ã«ãã现ããªããåŸæã«ã¯çèéã®å¢å ã«ãã倪ããªã£ããããã 3) æã ã®ä»åã®ç 究ãããBMI ãå€§è ¿åšå²åŸã«å¯Ÿããå€å°ã®åœ±é¿ã¯ã¿ããããããŠãšã¹ã / å€§è ¿åšå²åŸã®æž¬å®ã¯ãéåå¹æã®è©äŸ¡ã«ã¯æçšã§ãããšæãããã
ã»ã¹ã¯ã¯ããã®æå¹æ§ãã©ã€ããªã»ã±ã¢ããã³äºé²å»åŠã®èŠç¹ãããè³å€ç§å»
ã® Osborn æ°ã¯èæžã®äžã§ 27)ããå 霢ç ãäºé²ããããã®5 ã€ã®éåãšããŠããšããŠã1) ã¹ã¯ã¯ããïŒSquatïŒã 2) ã·ã§ã«ããŒãã¬ã¹ïŒoverhead pressïŒã 3) ããããªããïŒdeadliftïŒã 4) ã ã³ ã ã 㬠ã¹ïŒbench pressïŒã5) æž å é åïŒpull-up / chin-upïŒãæããããã®äžã§ã1) squat ããã¬ãŒãã³ã°ã®åºç€ã§ãããå šèº«ã®ãã¬ãŒãã³ã°ã§ãããšè¿°ã¹ãŠãããæ°ã¯ 20-80 æ³ç·æ§ 8762 åã®å€§èŠæš¡èª¿æ»ãåŒçšããŠãã28)ã18.9 幎芳å¯ããçµæãçåããŠããã®ã¯æãçåãä¿æããŠãã人ã ã§ãã£ãã
ãã£ãããã¹ã®æå°è Hagan æ°ã¯ã匷ãé·ãæ©èœçãªãã¬ãŒãã³ã°ã®ã³ããã瀺ãããã®äžã§ãä»åŸã®éåããªãšãŒã·ã§ã³ãå«ã 6 åã®åºæ¬åäœããããšãã 29)ãããã㯠1) ã¹ã¯ã¯ããïŒsquatïŒã2) ã©ã³ãžïŒlungeïŒã3) ããããªããé¢é£ïŒpull/dead lift/rowïŒã 4) ã³ã¢ãã¬ãŒãã³ã°é¢é£
ïŒpush/plank/hoverïŒã5) æ»ãéåïŒtwist: torso rotationïŒã 6) æ©è¡ïŒgait: walk/runïŒã§ãããã¹ã¯ã¯ããã®éèŠæ§ã瀺ããŠãããé«éœ¢è ã®ã¹ã¯ã¯ããã§ãéåžžæ³ïŒnormal squat; SQïŒã«å ããæ€ åãçšããã¹ã¯ã¯ããïŒchair squat; CSQ, æ€ åã®é«ã 43.8cmïŒãè©Šè¡ããã 30)ãCSQ ã§ã¯è¡é¢ç¯ã®å±æ²ããã倧ãããSQ ã§ã¯èã足éŠã®å±æ²ã倧ãããä»åŸãããã®æ¹æ³ã察象è ã«å¿ããèšåºå¿çšãå¯èœãšãªãã ããã
ã¬ãžã¹ã¿ã³ã¹éåã®åŒ·åºŠãšåæ°ã«ã€ããŠãçè¥å€§ã«ã¯70 ïœ 85 % 1 RM ã®åŒ·åºŠã§ 8 ïœ 12 åã®å埩㧠3 ã»ãããé± 2 ïœ 3 åãå°ãªããšã 8 ïœ 12 é±éã®ã¬ãžã¹ã¿ã³ã¹éåããçååäžã«ã¯ 80 % 1 RM 以äžã®åŒ·åºŠã§ 8 åãŸã§ã®å埩ã§3 ïœ 5 ã»ãããé± 3 åïŒæ°é±éã®ã¬ãžã¹ã¿ã³ã¹éåãæšå¥šãããŠãã 31)ã以äžã®ããã«ã察象è ãäžé«å¹Žã§ã¢ã³ããšã€ãžã³ã°ãéåçæ³ã®ç®çãªããã¹ã¯ã¯ããã«å ãçš®ã ã®ã¹ãã¬ããã軜ãçãã¬ããåããè¶³è °ãéãããšããã
ãã 32)ãä»åãç 究ã«çšãããã€ã¹ã¯ã¯ããã¯ã察象è ã«ãã£ãŠ
䜿ãæ¹ãç°ãªãïŒå³ 1ïŒããŸããã¢ã¹ãªãŒããäœåã¢ããã§äœ¿ãå Žåãè °ãäžããçšåºŠãæ·±ããæ·±ãé ã«ãã«ããã ããã«ããã©ã¬ã«ã§ã®å§¿å¢ã§è¡ããèéšãæ·±ãåŸãã«äœçœ®ããéå¿ãä¿æããããã«ãæã¯åæ¹ã§ãã£ãããšå£ãæãããªã©åºå®ç©ããã£ããæãã
äžæ¹ãäžé«å¹Žè ãå¥åº·å¢é²ã§äœ¿ãå Žåãè °ã®äœçœ®ã¯é«ããããŒãããã¯ã©ãŒã¿ãŒã§ãããéåžžãæ€ åã®èãããŒãã«ã®ç«¯ãæã§ã€ãã¿ã軜ãæ¯ããä¿æããªããè¡ããå®ã¯ãæ€ åãè£å©çã«äœ¿ãã®ã¯ãæ¥åžžçãªéåçæ³ã®ç¶ç¶ã«ãã©ã¹ãšãªãããšããã®ã¯ããŠã©ãŒã ã¢ãããã¹ãã¬ãããçèãã¬ãŒãã³ã°ãªã©ããäžé£ã®åäœãšããŠè¡ããããã§ãã 32)ãã€ãŸããã¹ãã¬ãããšããŠé žéšãè©ãäžèéšãå€§è ¿åé çããã ã¹ããªã³ã°ã¹ããµããã¯ãã®åéšäœãè¡ããçèãã¬ãŒãã³ã°ãšããŠã5 åéæ©è¡ãã¹ã¯ã¯ãããã€ãŸå ç«ã¡ãèã®å±æ²ãèã®äŒžå±ããªã©ãè¡ããã以äžãããæ€ åãšãã€ã¹ã¯ã¯ãããçšããŠãã¹ãã¬ãããšçèãã¬ãŒãã³ã°ãå«ãåèªã®ããã°ã©ã ãç°¡åã«äœæãæ¯æ¥ç¶ç¶ã§ããã
ãªããæ°ããæ代ã«ãããè©Šã¿ãšããŠãã«ã€ãã¯ãïŒKinectïŒãå©çšãããšã¢ã»ã¹ã¯ã¯ããèšç·Žæ¯æŽã·ã¹ãã ã®éçºãå ±åãããŠãã 33)ãæ¹æ³ã¯ã倪ãããšåºãå¹³è¡ã«ãªããŸã§è °ãèœãšãã1 ç§çšåºŠãã®ç¶æ ãä¿ã€ãšããããŒãã¹ã¯ã¯ããã§ããã®æ¹æ³ã§ãè¶³è °ã«å¯Ÿããå¹æãæåŸ ãããã
座äœãæ©è¡ãã¹ãããã«ããç³å°¿ç ããããªããšã®å ±åã¯ä»ã«ãã¿ãããã36 ïœ 80 æ³ã® 698 äŸã«å¯Ÿããç 究ããã 34)ããã®äžã§ã1) 1 æ¥ 2 æé座äœããç«äœãžç¿æ £ãå€ãããšãææã«ç©ºè ¹æè¡ç³ 2 % äœäžãäžæ§èèª 11 % äœäžãã¿ããã2) 座äœããæ©è¡ã§ã¯å¹æãé«ãã3) ç«äœããæ©è¡ã§ããé£åŸ 2 æéè¡ç³ãææã« 11 % äœäžãããšããã
ãã®ããã«ãæ©è¡ïŒã¹ãããã³ã°ïŒã®ç¿æ £ã¯ãè¡ç³ãããã£ãŒã«ã«ãã©ã¹ã®å¹æãã¿ããããã€ã¹ã¯ã¯ããã¯çæéãªããã倧ããªçèãžã®åºæ¿ã§ãããããèšåºçã«ãæçšæ§ããããšæãããã
æ¬ç 究ãéããŠãæã ã¯ç 究ã®éçãç¶ãã®ããã«èããŠãããã€ãŸã 1) ç 究ãã¶ã€ã³ãšããŠãã³ã³ãããŒã«çŸ€ããªããæ¯èŒã¯éåæéã®ååŸã§ã®è©äŸ¡ã«éãããŠããã 2) ãã®ä»å ¥æ¹æ³ä»¥å€ã«è¢«éšè ã«èŠåçã§å¥åº·çãªç掻ãéãããä»ã®äº€çµ¡å åã®ååšã®å¯èœæ§ãããã3) ä»å ¥ãäžæ¢ããããšã被éšè ã®ç掻ç¿æ £ã¯å ã®ç¶æ ã«æ»ãå¯èœæ§ãããã4) æ¬ç 究ãã¶ã€ã³ã§ã¯ãHbA1c å€ãäžéãããå åã¯ã¹ã¯ã¯ããã ããšã¯å€æã§ããªãããªã©ãæããããã
ã»ç³å°¿ç äºé²ã®éèŠæ§ç±³åœã¹ããŒãå»åŠåŠäŒïŒACSMïŒã«ãããéååŠæ¹ã®æ
éåæžç¬¬ 9 çãã§ã¯ 35, 36)ããã€ãªã¹ã¯ãæãã察象è ã«å¯Ÿããéååã®ãã§ãã¯è¡šãããã5 ã€ã®å€§åé¡ãšããŠã1) å¿èç ãšèšºæãããã 2) å¿èç ã®å¯èœæ§ããã 3) ç³å°¿ç ãš
ïŒ 8 ïŒ
Glycative Stress Research
ä» 10 é ç®äžå°ãªããšã 1 é ç®ã®å䜵ã 4) éçã®æ ¢æ§è èç ã 5) æ ¢æ§éå¡æ§èºçŸæ£ãšããã3) ã®äžã«ã幎霢ãç³å°¿ç ãé«è¡å§ãè質ç°åžžçãå«ç ãªã©ãå«ãŸããç³å°¿ç ã®éèŠæ§ãäŒãã£ãŠããã
äžæ¹ãæå 霢å»åŠã®äžã§ãç³å°¿ç ã®äºé²ã¯éåžžã«éèŠã§ãããæ ¶æ矩塟倧åŠçŸå¯¿è ç 究ã§æ±äº¬éœåšäœã®çŸå¯¿è 302人ã®ç æŽèª¿æ»ã®çµæãæãå€ãã£ãçŸæ£ã¯é«è¡å§ã§ãçœå éã骚æãå¿çŸæ£ãããã«ç¶ãã 37)ãçŸå¯¿è ããŸã£ããç æ°ãããªãããã§ã¯ãªããã極端ãªè¥æºãç©ããå°ãªããç æŽã§ãã£ãšãå°ãªãã®ã¯ç³å°¿ç ã§ãã£ãã70ã80 代ã®ç³å°¿ç 眹æ£çã 20 % çšåºŠã§ããããšãèãããšãçŸå¯¿è ã® 6 % ãšããå€ã¯æ¥µããŠäœããã¢ã³ããšã€ãžã³ã°å»åŠã®ç®æšã§ããå¥åº·é·å¯¿ã®éæã®ããã«ã¯ç³å°¿ç ãäºé²ããããšãç³å°¿ç ã®ç®¡çãå³æ Œã«è¡ãããšãéèŠã§ããã
ãæå 霢å»åŠã«ãããŠãç³åã«ããéè¡æ§å€åãäºé²ããããã«ãé«éœ¢è ã«ãããéåçæ³ã¯ã身è¿ã§å®äŸ¡ã§çæéã§ã§ããäœãããå¹æãæãããããã®ãããããã®ç¹ã§ããã€ã¹ã¯ã¯ããã¯éåžžã«å¹ççãªéåçæ³ãšãªããå¿èº«ã®å 霢ã«ãã£ãŠãå€åºãè€éãªæ©åšã®äœ¿çšãå°é£ãããã¯åå«ã«ãªããã¡ã®é«éœ¢è ã¯å€ãããŸããä»äººãšããã©ãŒãã³ã¹ãæ¯èŒãã以åã«ãåäœãå®éã§ããªãããæ欲ã倱ãå Žåãã¿ãããã
äžæ¹ãç¹å®ã®æ©äŒã«åºãããæºåããå®éã«åºãããŠåŸããããªãã¬ãã·ã¥æãæ°ããªåéãªã©ãå¿èº«ã®æŽ»åæºãšãªããããå¹æãããããããã©ã€ããªã»ã±ã¢ã§ã¯ããããã®äž¡é¢ã®é·æãçæãèæ ®ããŠããã®äººã«å¿ããæ¹æ³ã§è¡ãããšãå¿ èŠãšãªãã ããã
çµè«æ¬ç 究ã§ã¯ãéåçæ³ã®åšæ©ã»ãã€ã¹ã¯ã¯ãããçšããŠã
ç³å°¿ç æ£è ã«ãããéåçæ³ã®å¹æã 6 ã«ææ€èšããã61äŸã®è¢«éšè ã§å¹³å HbA1c å€ã 0.4 % ã®æ¹åãã¿ãããèå¯ãå ãããæ¬ç 究ã¯ãç³å°¿ç ã«å¯Ÿããéåçæ³ã®åºç€ããŒã¿ãšãªããä»åŸãã©ã€ããªã»ã±ã¢é åã§å¯Ÿè±¡è ã«å¿ããé©åãªéåçæ³ã®çºå±ã«åèã«ãªããã®ãšæãããã
è¬èŸããã³COIæ¬å ±åã®èŠæšã¯ã第 58 åæ¥æ¬ç³å°¿ç åŠäŒç·äŒïŒ2015 幎 5æãå±±å£ïŒã§å ±åãããåçºè¡šè ã«é¢é£ããŠãé瀺ãã¹ã COIé¢ä¿ã«ããäŒæ¥çã¯ãªãã
References 1) World Health Organization (WHO). Global recommenda-
tions on physical activity for health. WHO Press, Geneva, Switzerland, 2010.
2) Active Guide. Japanese official physical activity guidelines for health promotion. 2013. http://www0.nih.go.jp/eiken/info/pdf/active2013-e.pdf
3) Physical Activity 2011-12.: Australian Bureau of Statistics(ABS) 2013. Australian Health Survey, 2013
4) Department of Health, Australian Government. Australia'sphysical activity & sedentary behaviour guidelines for adults (18-64 Years). 2014 www.health.gov.au/internet/main/publishing.nsf/content/health-pubhlth-strateg-phys-act-guidelines#apaadult
5) Canadian Society for Exercise Physiology. Canadian physical activity guidelines and Canadian sedentary behaviour guidelines. 2013. (www.csep.ca/guidelines)
6) Thorp AA, Owen N, Neuhaus M, et al. Sedentary behaviorsand subsequent health outcomes in adults a systematicreview of longitudinal studies, 1996-2011. Am J Prev Med. 2011; 41:207-215.
7) Wilmot EG, Edwardson CL, Achana FA, et al. Sedentary time in adults and the association with diabetes, cardio-vascular disease and death: systematic review and meta-analysis. Diabetologia. 2012; 55: 2895-2905.
8) Biswas A, Oh PI, Faulkner GE, et al. Sedentary time and its association with risk for disease incidence, mortality, and hospitalization in adults: a systematic review and meta-analysis. Ann Intern Med. 2015; 162: 123-132.
9) Fleck SJ, Kraemer WJ. Designing resistance training program (3rd ed). p.13-52, Human Kinetics, Chicago, Illinois, 2004
10) Faigendaum A. Age-and sex related differences and their implications for resistance exercise, Baechle and Earle de: Essentials of strength training and conditioning 3rd ed. p.141-158, Human Kinetics, Chicago, Illinois, 2008
11) Peterson MD, Rhea MR, Sen A, et al. Resistance exercise for muscular strength in older adults: A meta-analysis. Ageing Res Rev. 2010; 9: 226-237.
12) Fried LP, Tangen CM, Walston J, et al. Cardiovascular health study collaborative research group: frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci. 2001; 56: M 146-156.
13) Locomotive Syndrome. The Japanese Orthopaedic Association. Jpn. Orthop. Assoc. 2007; 81: 585-589.
14) Nakamura K. Locomotive syndrome. Japanese Journal of Geriatrics. 2012; 49: 393-401.
15) Locomotive syndrome-pamphlet 2015. The Japanese Orthopaedic Association. https://www.joa.or.jp/jp/public/locomo/locomo_pamphlet_2015.pdf
16) Bando H, Yonei Y, Nakamura T. Investigation of quality of life in athletes from an anti-aging perspective. Primary Care. 2006; 4: 47-51.
17) Bando H, Yoshioka T, Yonei Y, et al. Investigation of QOLin middle-aged athletes. Applied Gerontology. 2008; 2: 66-70.
ïŒ 9 ïŒ
ç³å°¿ç ã«å¯Ÿããã¹ã¯ã¯ããã®å¹èœ
18) Bando H, Nakamura T, Yonei Y, et al. Lipid profile of masters athletes in ice-skating, a model of anti-aging research. Glycative Stress Research. 2015; 2: 52-57.
19) Kan M. HiSquat, new type of exercise equipment for squat movement. Pat. pending registration No. 3179684, (Oct.24, 2012). Product registration number 5611700. http://www.hi-squat-kan.com/
20) Kan M. Bando H(ed.). Build up your physique with HiSquat, leading to sound life until 100 years old. MedicalInformatics Service, 2014,
21) Krishnan S, Rosenberg L, Palmer JR. Physical activity andtelevision watching in relation to risk of type 2 diabetes: The black womenâs health study. Am J Epidemiol. 2009;169: 428-434.
22) Dunstan DW, Kingwell BA, Larsen R. Breaking up prolonged sitting reduces postprandial glucose and insulinresponses. Diabetes Care. 2012; 35: 976-983.
23) Lynch BM, Owen N. Too much sitting and chronic diseaserisk: steps to move the science forward. Ann Intern Med. 2015; 162: 146-147.
24) Mayor S. Prolonged sitting increases risk of serious illnessand death regardless of exercise, study finds. BMJ. 2015 Jan 19; 350:h306. doi: 10.1136/bmj.h306.
25) Inoue M, Iso H, Yamamoto S, et al. Daily total physical activity level and premature death in men and women: Results from a large-scale population-based cohort studyin Japan (JPHC study). Ann Epidemiol. 2008; 18: 522-530.
26) Inoue M, Yamamoto S, Kurahashi N , et al. Daily total physical activity level and total cancer risk in men and women: results from a large-scale population-based cohortstudy in Japan. Am J Epidemiol. 2008; 168: 391-403.
27) Osborn B. Get serious, a neurosurgeonâs guide to optimal health and fitness â for men and women of all ages. Book Publishers Network, 2014.
28) Ruiz JR, Sui X, Lobelo F, et al. Association between muscular strength and mortality in men: Prospective cohortstudy. BMJ 2008;337:a439 doi:10.1136/bmj.a439
29) Hagan M. Goodlife fitness: 6 weeks to a new body. PenguinCanada Publishing, 2008.
30) Flanagan S, Salem GJ, Wang MY, et al. Squatting exercises in older adults: kinematic and kinetic comparisons. Med Sci Sports Exerc. 2003; 35: 635-643.
31) Mayer F, Scharhag-Rosenberger F, Carlsohn A, Cassel M,MÃŒller S, Scharhag J : The intensity and effects of strengthtraining in the elderly. Dtsch Arztebl Int. 2011; 108: 359-364.
32) Seguin RA, Epping JN, Buchner DM et al. Growing Stronger-strength training for older adults. U.S. departmentof health and human services, Centers for disease control and prevention, Tufts University, 2002, p34-74.
33) Ochi Y. Development of an air-squat training support system using microsoft kinect. The Journal of Informationand Systems in Education. 2013; 30: 98-103.
34) Healy GN, Winkler EA, Owen N, et al. Replacing sitting time with standing or stepping: Associations with cardio-metabolic risk biomarkers. Eur Heart J. 2015; 36: 2643-2649.
35) Thompson PD, Arena R, Riebe D, et al. ACSMâs new preparticipation health screening recommendations from ACSMâs guidelines for exercise testing and prescription, ninth edition. Curr Sports Med Rep. 2013; 12: 215-217.
36) Pescatello LS, Riebe D, Arena R, American College of Sports Medicine. ACSMâs guidelines for exercise testing and prescription. 9th ed. Baltimore (MD): Lippincott Williams & Wilkins; 2014.
37) Takayama M, Hirose N, Arai Y, et al. Morbidity of Tokyo-area centenarians and its relationship to functional status. J Gerontol A Biol Sci Med Sci. 2007; 62: 774-782.